U.S., Jan. 31 -- ClinicalTrials.gov registry received information related to the study (NCT07378436) titled 'A Clinical Study of GK02 in Malignant Ascites' on Jan. 07.
Brief Summary: A single-arm, single-center, open-label clinical study comprising three cohorts, evaluating the safety, preliminary efficacy, and pharmacokinetic/ pharmacodynamic (PK/PD) characteristics of autologous tumor-reactive T cells (GK02) derived from malignant ascites caused by advanced solid tumors.
The trial initially plans to enroll 9 subjects with malignant ascites caused by advanced solid tumors.
Study Start Date: Sept. 16, 2025
Study Type: INTERVENTIONAL
Condition:
Malignant Ascites Caused by Advanced Solid Tumors
Intervention:
DRUG: GK02
Autologous tum...